Premium
Maiva Pharma Pvt. Ltd is in talks with private equity investors, including buyout funds, to raise $60-70 million (₹485 crore- ₹566 crore) in equity, said two people aware of the deal. The contract pharma manufacturer has appointed investment bank Avendus Capital to find potential suitors, the people cited above said on ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
